|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-8-1
|
|
pubmed:abstractText |
This study sought to assess the impact of the selective aldosterone blocker eplerenone on mortality 30 days after randomization in patients after acute myocardial infarction (AMI) with a left ventricular ejection fraction (LVEF) < or =40% and clinical signs of heart failure.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
pubmed-author:AschermannMichaelM,
pubmed-author:EPHESUS Investigators,
pubmed-author:GheorghiadeMihaiM,
pubmed-author:KrumHenryH,
pubmed-author:MartinezFelipeF,
pubmed-author:MukherjeeRobinR,
pubmed-author:NicolauJoseJ,
pubmed-author:PittBertramB,
pubmed-author:VincentJohnJ,
pubmed-author:WhiteHarveyH,
pubmed-author:ZannadFaiezF,
pubmed-author:van VeldhuisenDirk JDJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
2
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
425-31
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16053953-Aged,
pubmed-meshheading:16053953-Coronary Angiography,
pubmed-meshheading:16053953-Dose-Response Relationship, Drug,
pubmed-meshheading:16053953-Double-Blind Method,
pubmed-meshheading:16053953-Drug Administration Schedule,
pubmed-meshheading:16053953-Female,
pubmed-meshheading:16053953-Follow-Up Studies,
pubmed-meshheading:16053953-Heart Failure,
pubmed-meshheading:16053953-Heart Function Tests,
pubmed-meshheading:16053953-Humans,
pubmed-meshheading:16053953-Male,
pubmed-meshheading:16053953-Middle Aged,
pubmed-meshheading:16053953-Myocardial Infarction,
pubmed-meshheading:16053953-Probability,
pubmed-meshheading:16053953-Proportional Hazards Models,
pubmed-meshheading:16053953-Reference Values,
pubmed-meshheading:16053953-Severity of Illness Index,
pubmed-meshheading:16053953-Spironolactone,
pubmed-meshheading:16053953-Treatment Outcome,
pubmed-meshheading:16053953-Ventricular Dysfunction, Left
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
|
|
pubmed:affiliation |
University of Michigan School of Medicine, Ann Arbor, Michigan 48109, USA. bpitt@med.umich.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
